# Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor

> **NCT03807076** · NA · COMPLETED · sponsor: **University of Copenhagen** · enrollment: 25 (actual)

## Conditions studied

- Acromegaly Due to Pituitary Adenoma

## Interventions

- **OTHER:** GIP-A
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03807076
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-13
- **Primary completion:** 2023-06-14
- **Final completion:** 2023-11-28
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-11-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03807076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03807076, "Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03807076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*